Steatohepatitis

Infectious Disease·MeSH: Fatty Liver

Prevalence

5000.0 / 100K

Incidence

500.0 / 100K/yr

52 drugs in development·36 companies·1 clinical trial

Drug Pipeline by Phase

Approved(1)

Drug	Company
orbera	Apollo Endosurgery, Inc. (APEN)

Phase 3(12)

Drug	Company
100 mg resmetirom	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
cenicriviroc	Allergan plc (AGN)
Efruxifermin	Keros Therapeutics, Inc. (KROS)
efruxifermin (EFX)	Akero Therapeutics, Inc. (AKRO)
iva337	Inventiva S.A. (IVA)
iva337	Inventiva S.A. (IVEVF)
mgl-3196	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Pegozafermin	89bio, Inc. (ETNB)
Pitolisant oral tablets	Crinetics Pharmaceuticals, Inc. (CRNX)
Resmetirom	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
UBT251	UNITED THERAPEUTICS Corp (UTHR)
Vortioxetine tablets	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 2(21)

Drug	Company
aln-hsd	REGENERON PHARMACEUTICALS, INC. (REGN)
BIO89-100	89bio, Inc. (ETNB)
efruxifermin	Akero Therapeutics, Inc. (AKRO)
EFX	Akero Therapeutics, Inc. (AKRO)
ervogastat	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
fxr314	VivoSim Labs, INC. (VIVS)
hm15211	ANI PHARMACEUTICALS INC (ANIP)
hu6	West Pharmaceutical Services Inc. (WST)
hu6	Corvus Pharmaceuticals, Inc. (CRVS)
MLR-1023	Adhera Therapeutics, Inc. (ATRX)
ngm282	NGM BIOPHARMACEUTICALS INC (NGM)
nnc0174 0833	Novo Nordisk A/S (NVO)
nnc0194 0499	Novo Nordisk A/S (NVO)
PLN-1474	PLIANT THERAPEUTICS, INC. (PLRX)
ptm cilo/fir	GILEAD SCIENCES, INC. (GILD)
ptm sema	GILEAD SCIENCES, INC. (GILD)
Rencofilstat (formerly CRV431; CPI-431-32)	Hepion Pharmaceuticals, Inc. (CTRVP)
rencofilstat (formerly CRV431)	Hepion Pharmaceuticals, Inc. (CTRVP)
seladelpar	CymaBay Therapeutics, Inc. (CBAY)
Synthroid	ENANTA PHARMACEUTICALS INC (ENTA)
tvb-2640	Sagimet Biosciences Inc. (SGMT)

Phase 1(12)

Drug	Company
ACT500 tablets	Crinetics Pharmaceuticals, Inc. (CRNX)
aln-cideb	REGENERON PHARMACEUTICALS, INC. (REGN)
aramchol free acid	Galmed Pharmaceuticals Ltd. (GLMD)
ARO-HSD Injection	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARO-PNPLA3	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
cotadutide	ASTRAZENECA PLC (AZN)
hec169584	SUNSHINE BIOPHARMA INC. (SBFM)
MGL-2086	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
miricorilant	CORCEPT THERAPEUTICS INC (CORT)
ontamalimab	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
ontamalimab	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tern-501	Terns Pharmaceuticals, Inc. (TERN)

Preclinical(4)

Drug	Company
electroceuticals therapeutic devices	ENDONOVO THERAPEUTICS, INC. (ENDV)
jkb-122	Biostax Corp. (BTAX)
siRNA programs	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
siRNA targeting Beta2-spectrin	Bullfrog AI Holdings Inc. (BFRG)

Phase 1/Phase 2(2)

Drug	Company
ft-4101	Forma Therapeutics Holdings, Inc. (FMTX)
ft-8225	Forma Therapeutics Holdings, Inc. (FMTX)

BioSniper tracks 52 drugs in development for Steatohepatitis across 36 companies.

There are 1 clinical trial targeting Steatohepatitis tracked by BioSniper.

The estimated prevalence of Steatohepatitis is approximately 5000.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.